141 related articles for article (PubMed ID: 21571206)
1. Treatment of refractory chronic urticaria with tumor necrosis factor-alfa inhibitors.
Wilson LH; Eliason MJ; Leiferman KM; Hull CM; Powell DL
J Am Acad Dermatol; 2011 Jun; 64(6):1221-2. PubMed ID: 21571206
[No Abstract] [Full Text] [Related]
2. Successful treatment of delayed pressure urticaria with anti-TNF-alpha.
Magerl M; Philipp S; Manasterski M; Friedrich M; Maurer M
J Allergy Clin Immunol; 2007 Mar; 119(3):752-4. PubMed ID: 17336621
[No Abstract] [Full Text] [Related]
3. Hypersensitivity reactions during treatment with infliximab, etanercept, and adalimumab.
Puxeddu I; Giori L; Rocchi V; Bazzichi L; Bombardieri S; Tavoni A; Migliorini P; Del Corso I
Ann Allergy Asthma Immunol; 2012 Feb; 108(2):123-4. PubMed ID: 22289732
[No Abstract] [Full Text] [Related]
4. Lack of anti-drug antibodies in patients with psoriasis well-controlled on long-term treatment with tumour necrosis factor inhibitors.
Meyer MW; Zachariae C; Bendtzen K; Skov L
Acta Derm Venereol; 2012 Jul; 92(4):362-4. PubMed ID: 22864558
[No Abstract] [Full Text] [Related]
5. Severe cutaneous reaction and fever due to adalimumab.
Gonzalo-Garijo MA; Rodríguez-Nevado I; Pérez-Calderón R; Sánchez-Vega S; Pérez-Rangel I
Ann Allergy Asthma Immunol; 2010 Dec; 105(6):490-1. PubMed ID: 21130390
[No Abstract] [Full Text] [Related]
6. Tumor necrosis factor inhibitors for rheumatoid arthritis.
Scott DL; Kingsley GH
N Engl J Med; 2006 Aug; 355(7):704-12. PubMed ID: 16914706
[No Abstract] [Full Text] [Related]
7. Nodular melanoma arising in a patient treated with anti-tumor necrosis factor alpha antagonists.
Carlesimo M; La Pietra M; Arcese A; Di Russo PP; Mari E; Gamba A; Orsini D; Camplone G
Int J Dermatol; 2012 Oct; 51(10):1234-6. PubMed ID: 22416995
[No Abstract] [Full Text] [Related]
8. Switching tumor necrosis factor alpha inhibitors in HLA-B27-associated severe heel enthesitis.
Olivieri I; Scarano E; Padula A; D'angelo S; Cantini F
Arthritis Rheum; 2007 Dec; 57(8):1572-4. PubMed ID: 18050233
[No Abstract] [Full Text] [Related]
9. [Review of the protective effects of tumor necrosis factor inhibitors in rheumatoid arthritis].
Finckh A; Gabay C; Guerne PA
Rev Med Suisse Romande; 2004 Sep; 124(9):547-50. PubMed ID: 15552748
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor necrosis factor alpha therapy in psoriatic arthritis and psoriasis.
Girolomoni G; Abeni D
Arch Dermatol; 2001 Jun; 137(6):784-5. PubMed ID: 11405771
[No Abstract] [Full Text] [Related]
11. Anti-tumor necrosis factor alpha therapy and heart failure: what have we learned and where do we go from here?
Khanna D; McMahon M; Furst DE
Arthritis Rheum; 2004 Apr; 50(4):1040-50. PubMed ID: 15077286
[No Abstract] [Full Text] [Related]
12. Successful use of infliximab following a failed course of etanercept in a pediatric patient.
Farnsworth NN; George SJ; Hsu S
Dermatol Online J; 2005 Dec; 11(3):11. PubMed ID: 16409907
[No Abstract] [Full Text] [Related]
13. Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents.
Koumakis E; Wipff J; Avouac J; Kahan A; Allanore Y
J Rheumatol; 2009 Sep; 36(9):2125-6. PubMed ID: 19738227
[No Abstract] [Full Text] [Related]
14. Etanercept is effective in patients with rheumatoid arthritis with no response to infliximab therapy.
Gómez-Puerta JA; Sanmartí R; Rodríguez-Cros JR; Cañete JD
Ann Rheum Dis; 2004 Jul; 63(7):896. PubMed ID: 15194598
[No Abstract] [Full Text] [Related]
15. [European and British recommendations on the role of biologic interventions in moderate to severe psoriasis].
Bachelez H; Battistella M
Ann Dermatol Venereol; 2011 Apr; 138(2 Suppl 2):H14-7. PubMed ID: 21703457
[No Abstract] [Full Text] [Related]
16. Tumor necrosis factor inhibitors in the treatment of chronic inflammatory diseases. A review of immunogenicity and potential implications.
Flood J
Manag Care; 2009 Apr; 18(4 Suppl 3):1-5. PubMed ID: 19562866
[No Abstract] [Full Text] [Related]
17. Sensorineural hearing loss in ankylosing spondylitis treated with TNF blockers.
Savastano M; Marioni G; Giacomelli L; Ramonda R; Ferraro SM; Punzi L
B-ENT; 2010; 6(3):183-8. PubMed ID: 21090160
[TBL] [Abstract][Full Text] [Related]
18. Switching to adalimumab in patients with moderate to severe psoriasis who have failed on etanercept: a retrospective case cohort study.
Woolf RT; Smith CH; Robertson K; Barker JN
Br J Dermatol; 2010 Oct; 163(4):889-92. PubMed ID: 20854408
[No Abstract] [Full Text] [Related]
19. Successful treatment of systemic cold contact urticaria with etanercept in a patient with psoriasis.
Gualdi G; Monari P; Rossi MT; Crotti S; Calzavara-Pinton PG
Br J Dermatol; 2012 Jun; 166(6):1373-4. PubMed ID: 22212112
[No Abstract] [Full Text] [Related]
20. Anti-TNF-alpha therapy in childhood pustular psoriasis.
Pereira TM; Vieira AP; Fernandes JC; Antunes H; Basto AS
Dermatology; 2006; 213(4):350-2. PubMed ID: 17135745
[No Abstract] [Full Text] [Related]
[Next] [New Search]
